יחס חוב לטווח קצר להון עצמי: usana.com (USNA)

The price chart for USANA Health Sciences (USNA) demonstrates a debt-to-equity ratio of 0.00. This metric is complemented by the implementation of unmanned warehouse systems alongside nearly full automation of production facilities. The business relies on the global distribution of functional products across Europe, Asia, and the US, thereby minimizing regional threats. Strict FDA oversight and colossal brand development costs ensure a high barrier to entry.

This indicator assesses financial stability through the ratio of liabilities with a maturity exceeding one year to net equity, determining liquidity risk and the efficiency of the debt load. By analyzing the ratio of short-term borrowed capital to equity, an investor can see how the closed-loop logistics chain of USANA Health Sciences minimizes the need for borrowing, maintaining high margins and protecting the balance sheet from cash flow gaps.